These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6396097)
41. Glucose-induced hyperkalaemia: A hazard for diabetics? Viberti GC Lancet; 1978 Apr; 1(8066):690-1. PubMed ID: 76227 [TBL] [Abstract][Full Text] [Related]
42. [Safe treatment of acute hyperkalemia : The 1:4 and other principles]. Groene P; Hoffmann G Anaesthesist; 2017 Jun; 66(6):426-430. PubMed ID: 28409198 [TBL] [Abstract][Full Text] [Related]
43. Captopril and resistant ascites: a word of caution. Ring T Lancet; 1983 Jul; 2(8342):165. PubMed ID: 6135009 [No Abstract] [Full Text] [Related]
44. Developing strategies for predicting hyperkalemia in potassium-increasing drug-drug interactions. Eschmann E; Beeler PE; Schneemann M; Blaser J J Am Med Inform Assoc; 2017 Jan; 24(1):60-66. PubMed ID: 27174894 [TBL] [Abstract][Full Text] [Related]
45. Captopril: five years on. Hodsman GP; Robertson JI Br Med J (Clin Res Ed); 1983 Sep; 287(6396):851-2. PubMed ID: 6412854 [No Abstract] [Full Text] [Related]
46. [Clinical signs and diagnosis of hyperkalemia]. Stein G; Ritz E Dtsch Med Wochenschr; 1990 Jun; 115(23):899-902. PubMed ID: 2191844 [No Abstract] [Full Text] [Related]
47. A possible role for insulin in the prevention of glucose-induced paradoxical hyperkalemia during sodium depletion. Radó JP Horm Metab Res; 1980 Jul; 12(7):338-9. PubMed ID: 6995253 [No Abstract] [Full Text] [Related]
48. Captopril and insulin sensitivity. Ferriere M; Lachkar H; Richard JL; Bringer J; Orsetti A; Mirouze J Ann Intern Med; 1985 Jan; 102(1):134-5. PubMed ID: 3881067 [No Abstract] [Full Text] [Related]
49. The effect of aldosterone on the blood glucose concentration in rabbits. Masumura S Nihon Seirigaku Zasshi; 1972 Jul; 34(7):437-8. PubMed ID: 4676192 [No Abstract] [Full Text] [Related]
50. [Intestinal absorption of potassium]. Classen HG; Marquardt P; Späth M Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):122-39. PubMed ID: 5353872 [No Abstract] [Full Text] [Related]
52. Captopril-induced creatine kinase elevations: a possible role of the sulfhydryl group. Katayama S; Inaba M; Maruno Y; Omoto A; Itabashi A; Kawazu S; Ishii J; Komine S; Furuhata T Hypertension; 1987 Aug; 10(2):234-6. PubMed ID: 3301668 [No Abstract] [Full Text] [Related]
53. A role for the upright posture in the development of glucose-induced hyperkalemia; prevention by a mineralocorticoid. Radó JP Horm Metab Res; 1982 Oct; 14(10):551. PubMed ID: 6757090 [No Abstract] [Full Text] [Related]
54. Pseudohyperkalemia and platelet counts. Nijsten MW; de Smet BJ; Dofferhoff AS N Engl J Med; 1991 Oct; 325(15):1107. PubMed ID: 1891016 [No Abstract] [Full Text] [Related]
55. Changes of the serum potassium level in the course of double glucose tolerance tests. BARTA L; BORSOLI L; HORN Z Paediatr Danub; 1948 Aug; 4(2):59-64. PubMed ID: 18883987 [No Abstract] [Full Text] [Related]
56. An unusual case of hyperkalaemia. Hembling IM; Pledger DR; Fowler D Ann Clin Biochem; 1996 Jan; 33 ( Pt 1)():89-91. PubMed ID: 8929078 [No Abstract] [Full Text] [Related]
57. A Brother and Sister with Fluctuating Potassium Concentrations. Vos MJ; Bouwhuis JW; Dikkeschei LD Clin Chem; 2019 Mar; 65(3):378-380. PubMed ID: 30819789 [No Abstract] [Full Text] [Related]
58. The first symptom of hyperkalemia is death. Grossman CM ACP J Club; 2004; 141(2):A14; author reply A15. PubMed ID: 15341476 [No Abstract] [Full Text] [Related]